TFF
AVNS icon

The Family Firm’s Avanos Medical AVNS Stock Holding History

The Family Firm’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-249
Closed -$4.96K – 251
2024
Q2 		$4.96K Buy
+249
New +$4.85K ﹤0.01% 736

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

The Family Firm's AVNS Position: Q3 2024 in Review

The Family Firm sold out of Avanos Medical (AVNS) in Q3 2024, closing a stake of 249 shares — an estimated $4.96K sold.

The Family Firm first reported a position in AVNS in Q2 2024 and held it in 1 quarter. The position peaked at $4.96K in Q2 2024. 260 funds tracked by Wall St. Rank hold AVNS as of Q3 2024.

  • The Family Firm reported no remaining Avanos Medical position as of Q3 2024 after selling out during the quarter.
  • The Family Firm sold 249 Avanos Medical shares in Q3 2024, an estimated $4.96K.
  • The Family Firm first reported a position in Avanos Medical in Q2 2024 and held it in 1 quarter.
  • The Family Firm's Avanos Medical position peaked at $4.96K in Q2 2024.
  • 260 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2024.

Based on The Family Firm's 13F filing for Q3 2024, filed 17 Oct 2024.